Charity-run funds that are helping patients pay high co-payments are facing new scrutiny by prosecutors. The Department of Health has stepped up their oversight of patient groups’ relationships with pharmaceutical companies in an effort to stop groups favoring patients on certain drugs.
Published by Jayne O’Donnell on 6/8/16